Sign In
Buy EVLO
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Evelo Biosciences to Report First Quarter 2020 Financial Results on Monday, May 11, 2020
01:00pm, Monday, 04'th May 2020
Evelo Biosciences (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that it will host a conference call and l
Bio Roundup: Alnylam's Billions, COVID-19 Vaccines, Moma Debuts & More
01:28pm, Friday, 17'th Apr 2020
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn't the only way for biotech companies to
Evelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer
11:00am, Wednesday, 15'th Apr 2020
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced the appointment of biopharmaceutica
Evelo Biosciences Appoints Neil Graham, M.D., M.B.B.S., M.P.H., as Chief Development Officer
11:00am, Wednesday, 15'th Apr 2020
Industry veteran brings deep experience in drug development from leadership roles at Regeneron and Vertex
Incyte details late-stage data on ruxolitinib cream for atopic dermatitis
06:55pm, Sunday, 05'th Apr 2020
Following up on its initial announcements in January and February, Incyte (NASDAQ:INCY) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2, evaluating a topica
Repertoire Immune Medicines Launches Type 1 Diabetes Focused Program with Investment from JDRF T1D Fund
01:00pm, Wednesday, 25'th Mar 2020
Repertoire Immune Medicines, a newly launched company working to unleash the curative power of the immune system to prevent and cure disease, today announced an investment from the JDRF T1D Fund, a ve
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Flagship Pioneering Announces the Launch of Repertoire Immune Medicines with Industry Veteran John G. Cox as Chief Executive Officer
01:00pm, Thursday, 12'th Mar 2020
Flagship Pioneering, a life sciences innovation enterprise, announced the launch of Repertoire Immune Medicines, a clinical-stage biotechnology compan
Evelo Announces Issuance of U.S. Patent Covering Use of Proprietary Bifidobacterium animalis ssp. lactis Strain for Treating Cancer
12:00pm, Thursday, 05'th Mar 2020
The Evelo-owned patent covers the use of a proprietary Bifidobacterium strain for the treatment of cancer, including use in combination with anti-PD-1 antibodies and other checkpoint inhibitors, and i
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced biomarker data for EDP1815, its lea
Analysts: 3 Healthcare Stocks to Buy on Coronavirus Weakness
05:09pm, Tuesday, 25'th Feb 2020
With the coronavirus outbreak spreading rapidly in countries beyond China, so is the fear among investors. Yesterday marked the S&P 500’s worst one-day performance since February 2018 as the index s
Evelo Biosciences to Present at 40th Annual Cowen Health Care Conference
12:00pm, Tuesday, 25'th Feb 2020
CAMBRIDGE, Mass., Feb. 25, 2020 -- Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically.
Cowen & Co. Maintains Their Buy Rating on Evelo Biosciences (EVLO)
11:26am, Friday, 14'th Feb 2020
In a report released today, Chris Shibutani from Cowen & Co. maintained a Buy rating on Evelo Biosciences (EVLO). The company's shares closed last
Cowen & Co. Maintains Their Buy Rating on Evelo Biosciences (EVLO)
11:26am, Friday, 14'th Feb 2020
In a report released today,
Chris Shibutani
from Cowen & Co. maintained a
Buy
rating on Evelo Biosciences (
EVLO
–
Research Report
). The company’s shares closed last Monday at $4.39, close to its
The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO
01:05pm, Thursday, 13'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (N
